GILD vs HCA
Gilead Sciences vs HCA Healthcare — AI-powered side-by-side comparison
GILD
Gilead Sciences
51
Watch
VS
HCA
HCA Healthcare
56
Buy
| Metric | GILD | HCA |
|---|
| AI Score |
51
|
56
|
| Price |
$148.12
|
$426.87
|
| P/E Ratio |
-57.22×
|
14.31×
|
| ROE |
37.5%
|
-112.6%
|
| Revenue Growth YoY |
—
|
—
|
| Gross Margin |
79.6%
|
28.4%
|
| Debt / Equity |
2.22×
|
-7.42×
|
| Dividend Yield |
2.2%
|
0.7%
|
| RSI (14) |
76.0
|
71.1
|
| Beta |
0.336
|
1.109
|
| Expected Upside |
+5.7%
|
+0.1%
|
AI Committee View
Current Innellis committee reasoning for GILD versus HCA.
HCA leads by 5 points.
HCA scores 56/100 (Buy) versus GILD at 51/100 (Watch).
GILD Committee View
50% agreement
6 analysts
The committee is genuinely divided. Macro Analyst sees a compelling case. Value Analyst remains cautious — price-to-book of 6.7x prices in significant intangible value. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- Dividend yield of 4.0% pays you to wait — Value
- 5 consecutive earnings beats -- consistent execution — Growth
- Price structure making higher highs and higher lows — Technical
Bear Case
- Price-to-book of 6.7x prices in significant intangible value — Value
- ROE of only -16.3% -- cheap may mean cheap for a reason — Value
- Growth rate is decelerating quarter over quarter -- the trend line matters more than the level — Growth
HCA Committee View
50% agreement
6 analysts
The committee is genuinely divided. Growth Analyst sees a compelling case — eps growing 25.5% yoy. Risk Analyst remains cautious — high leverage (debt-to-equity 54.20) amplifies downside in a stress scenario. This disagreement is itself the signal — the setup is not clean in either direction.
Bull Case
- P/E of 12.9 is inexpensive for the broad market — Value
- ROE of 695.7% shows genuine earnings power backing the valuation — Value
- EPS growing 25.5% YoY — Growth
Bear Case
- Price-to-book of 97.3x prices in significant intangible value — Value
- Debt-to-equity of 54.20 adds balance-sheet risk to the value case — Value
- RSI at 72 is in overbought territory — Technical